BeiGene (NASDAQ:BGNE), a global biotechnology company, announced the appointment of Titus Ball (NYSE:BALL) as the new principal accounting officer, effective March 19, 2024. The role was previously held by Julia Wang, who will continue her duties as the Chief Financial Officer and principal financial officer of the company.
Titus Ball, 51, joined BeiGene in August 2023 as Vice President, Chief Accounting Officer. His extensive experience in finance includes a recent role as Managing Director in KPMG's Accounting Advisory practice from 2022 to 2023.
Ball's career also spans over a decade at Carlisle Companies (NYSE:CSL) Inc., where he served in various finance roles of increasing responsibility, culminating in his position as VP of Finance for Carlisle's Fluid Technologies segment and as VP & Chief Accounting Officer for Carlisle Companies Inc . He began his career as an Audit Senior Manager at PricewaterhouseCoopers.
Ball holds a B.A. in Economics and Business Administration from King University. His appointment to the principal accounting officer position at BeiGene is seen as part of the company's ongoing efforts to strengthen its financial leadership team.
This leadership transition comes as BeiGene continues to expand its global presence in the biotechnology sector. The company is known for its focus on developing innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer.
The information provided in this article is based on a recent SEC filing by BeiGene.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.